Real-world effectiveness of peginterferon α-2b plus ribavirin in a Canadian cohort of treatment-naïve chronic hepatitis C patients with genotypes 2 or 3: results of the PoWer and RediPEN studies
Marotta, P., Bailey, R., Elkashab, M., Farley, J., Feinman, S. V., Peltekian, K., Poliquin, M., Witt-Sullivan, H., Rampakakis, E., Drolet, M., Cooper, C.Volume:
35
Language:
english
Journal:
European Journal of Clinical Microbiology & Infectious Diseases
DOI:
10.1007/s10096-016-2576-1
Date:
April, 2016
File:
PDF, 407 KB
english, 2016